Strategic Consulting and Advisory Services
Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Software Portfolio: 'End-to-end' Modeling
Certara biosimulation (model based drug development and informatics) software portfolio is the most wide-ranging in the industry. Certara technology is relied upon by over 1,500 biopharm companies and academic institutions for drug research and development.
Certara's Programmatic Consulting Approach Delivers Unquestionable Value to Sponsor Companies
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
Leading Edge Science: Resource Library
Check out the latest brochures, case studies, white papers, webinars, and more! Search by keywords and/or filter results.
Press Releases
Former Director of Clinical Pharmacology at CDER Joins Certara’s Simcyp Scientific Advisory Board
August 20, 2015
Dr. Lawrence J. Lesko’s selection underscores biosimulation’s integral role in the drug development process
Certara Head of Simcyp Translational Science Appointed to Xenobiotica Editorial Board
August 10, 2015
Dr. Iain Gardner will play an active role in the monthly journal’s peer-review process and help to maintain its high editorial standards.
Certara CEO Honored in PharmaVOICE 100
August 05, 2015
Dr. Muniz Named as One of the 100 Most Inspiring Leaders in the Life Science Industry
Dan Littman to Give Keynote at Lasker Workshop for International Research Students
August 04, 2015
Presenters will share best practices and discuss personal experiences pertaining to getting scientific research published
Certara Launches Its Simcyp In Vitro Analysis Toolkit to Improve Drug Discovery & Development
July 29, 2015
This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers.
Certara Appoints Tristen Herrstrom as Senior Vice President of Human Resources
July 16, 2015
Ms. Herrstrom will focus on enhancing talent acquisition, leadership development, and other key growth initiatives.
Certara Creates Preeminent Global Strategic Modeling and Simulation Consultancy
July 08, 2015
New Entity Combines Certara’s Leading Model-based Drug Development Business with Scientific Powerhouse, Quantitative Solutions
Certara Endows Lectureship in Precision Dosing at The University of Manchester, England
June 03, 2015
New academic collaboration will help to advance precision medicine efforts to deliver the right treatment to patients at the right time
Certara Experts to Host Two Workshops and Present Ten Posters at PAGE 2015
May 28, 2015
Certara also contributes to a student scholarship fund to ensure that aspiring pharmacometrics researchers can attend the conference
WCG and Certara Co-sponsor Lasker Leadership Events for International Medical Research Students
May 19, 2015
Support will include the inaugural Lasker Lessons in Leadership series in the US and NIH Global Doctoral Partnerships Annual Research Colloquium in the UK
Synchrogenix & CISCRP Partner to Help Biopharm Companies Meet Clinical Data Transparency Mandates
April 23, 2015
The Center for Information and Study on Clinical Research Participation (CISCRP) and Synchrogenix, Certara's regulatory writing consultancy, are collaborating to develop lay summaries of clinical trials for the general public
Certara Launches its Cardiac Safety Simulator V2.0
April 02, 2015
New biosimulation solution addresses drug candidates’ cardiotoxicity risk
Certara Supported Risk Assessment Research Wins Outstanding Paper Award
March 27, 2015
Authored by The Hamner Institutes for Health Sciences, the EPA, and Certara, this award-winning paper uses high-throughput toxicity testing to compare susceptibility between populations
Aaron Bernstein Appointed to Group Updating Guidelines on Clinical Study Protocols and Reports
March 19, 2015
Dr. Bernstein will work with the Budapest Working Group to update International Conference on Harmonisation guidelines for developing clinical study protocols and reports
Certara Opens Larger Corporate Headquarters in Princeton, NJ
March 17, 2015
Company plans to expand its executive, business development, science, sales, and marketing teams
Certara Consultants to Discuss Advances in Biosimulation & PK/PD Modeling at ASCPT Annual Meeting
March 05, 2015
Certara is contributing to 12 presentations and poster sessions at this year’s conference
Japanese Regulatory Agency Licenses Certara’s Phoenix and Simcyp Software
February 26, 2015
Pharmaceuticals and Medical Devices Agency (PMDA) is equipping its pharmacometrics team with Certara’s biosimulation software
Certara Donates Software to University of Maryland to Develop New Approaches to Drug Development
February 19, 2015
Gift of Phoenix® software licenses, workshop assistance, and training renews the strong partnership established between the two organizations in 2012
Certara Reinforces D360’s Position as Dominant Big Data Platform for the Biopharmaceutical Industry
February 17, 2015
D360 version 8.0 supports connections to broader and more diverse data sets, increases collaboration across silos, and delivers faster time to insight for scientific decision making